KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityGoodwillGoodwill & IntangiblesIntangiblesInterest DepositsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetLoans - NetLong-Term InvestmentsNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - AccuredReceivables - OtherRetained EarningsSecuritiesSecurities - Held-to-maturitySecurities - TradableShareholder's EquityShares OutstandingShort term DebtTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Peoples Bancorp (PEBO) Cash & Equivalents (2016 - 2026)

Peoples Bancorp (PEBO) has disclosed Cash & Equivalents for 11 consecutive years, with $190.4 million as the latest value for Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 1.83% year-over-year to $190.4 million; the TTM value through Mar 2026 reached $190.4 million, up 1.83%, while the annual FY2025 figure was $189.0 million, 13.19% down from the prior year.
  • Cash & Equivalents hit $190.4 million in Q1 2026 for Peoples Bancorp, up from $189.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $429.7 million in Q1 2024 and bottomed at $15.0 million in Q4 2022.
  • Average Cash & Equivalents over 5 years is $217.4 million, with a median of $190.2 million recorded in 2025.
  • Year-over-year, Cash & Equivalents tumbled 62.73% in 2023 and then surged 1169.25% in 2024.
  • Peoples Bancorp's Cash & Equivalents stood at $15.0 million in 2022, then rose by 14.24% to $17.1 million in 2023, then soared by 1169.25% to $217.7 million in 2024, then decreased by 13.19% to $189.0 million in 2025, then rose by 0.76% to $190.4 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $190.4 million, $189.0 million, and $190.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.